OpenURL Connection Search

Select item for more details and to access through your institution.

IL-25 blockade augments antiviral immunity during respiratory virus infection.
Published in:
Communications Biology, 2022, v. 5, n. 1, p. 1, doi. 10.1038/s42003-022-03367-z
By:
- Williams, Teresa C.;
- Loo, Su-Ling;
- Nichol, Kristy S.;
- Reid, Andrew T.;
- Veerati, Punnam C.;
- Esneau, Camille;
- Wark, Peter A. B.;
- Grainge, Christopher L.;
- Knight, Darryl A.;
- Vincent, Thomas;
- Jackson, Crystal L.;
- Alton, Kirby;
- Shimkets, Richard A.;
- Girkin, Jason L.;
- Bartlett, Nathan W.
Publication type:
Article
Upper respiratory tract OC43 infection model for investigating airway immune-modifying therapies.
Published in:
American Journal of Respiratory Cell & Molecular Biology, 2023, v. 69, n. 6, p. E1, doi. 10.1165/rcmb.2023-0202ma
By:
- Girkin, Jason L. N.;
- Bryant, Nathan E.;
- Su-Ling Loo;
- Hsu, Alan;
- Kanwal, Amama;
- Williams, Teresa C.;
- Maltby, Steven;
- Turville, Stuart G.;
- Wark, Peter A. B.;
- Bartlett, Nathan W.
Publication type:
Article
Toll-like receptor-agonist-based therapies for respiratory viral diseases: thinking outside the cell.
Published in:
European Respiratory Review, 2022, v. 31, n. 164, p. 1, doi. 10.1183/16000617.0274-2021
By:
- Girkin, Jason L. N.;
- Maltby, Steven;
- Bartlett, Nathan W.
Publication type:
Article
Corticosteroid suppression of antiviral immunity increases bacterial loads and mucus production in COPD exacerbations.
Published in:
Nature Communications, 2018, v. 9, n. 1, p. 1, doi. 10.1038/s41467-018-04574-1
By:
- Singanayagam, Aran;
- Glanville, Nicholas;
- Yee Man Ching;
- Marcellini, Andrea;
- Porter, James D.;
- Toussaint, Marie;
- Walton, Ross P.;
- Finney, Lydia J.;
- Aniscenko, Julia;
- Jie Zhu;
- Trujillo-Torralbo, Maria-Belen;
- Calderazzo, Maria Adelaide;
- Solari, Roberto;
- Edwards, Michael R.;
- Mallia, Patrick;
- Johnston, Sebastian L.;
- Bartlett, Nathan W.;
- Girkin, Jason L.;
- Grainge, Chris;
- Su-Ling Loo
Publication type:
Article

Found: 4

IL-25 blockade augments antiviral immunity during respiratory virus infection.

Upper respiratory tract OC43 infection model for investigating airway immune-modifying therapies.

Toll-like receptor-agonist-based therapies for respiratory viral diseases: thinking outside the cell.

Corticosteroid suppression of antiviral immunity increases bacterial loads and mucus production in COPD exacerbations.